The Dutch competition authority has fined pharmaceutical company Leadiant Biosciences almost €20 million after it found the company responsible forsetting excessive prices for the sale of one of its drugs.

We understand Legal Issues in Asia
The Dutch competition authority has fined pharmaceutical company Leadiant Biosciences almost €20 million after it found the company responsible forsetting excessive prices for the sale of one of its drugs.